Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics
Mohammad Hossein Harirchian
Mohammad Hossein Harirchian

Professor of Neurology

Department Neurology

School of Medicine

Imam Khomeini Hospital Complex

Iranian Center of Neurological Research

Tehran University of Medical Sciences

All Documents
1. Osteopontin in Alzheimer's Disease: A Double-Edged Sword in Neurodegeneration and Neuroprotection—A Systematic Review, CNS Neuroscience and Therapeutics (2025)
2. Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study, Heliyon (2024)
3. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
4. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
5. Biomechanical Changes of the Common Carotid Artery and Internal Jugular Vein in Patients With Multiple Sclerosis, Ultrasonography (2023)
6. Dietary Fish Intake and Multiple Sclerosis: A New Narrative, Diet and Nutrition in Neurological Disorders (2023)
7. Investigating the Occupational Performance Problems in Individuals With Multiple Sclerosis in Relapsing-Remitting Phase:Across-Sectional Study, Journal of Modern Rehabilitation (2023)
8. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
9. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
10. Linking Diet and Gut Microbiota in Multiple Sclerosis, Diet and Nutrition in Neurological Disorders (2023)
11. The Association of Serum Carnitine Levels With Severity of Fatigue in Patients With Multiple Sclerosis: A Pilot Study, Current Journal of Neurology (2023)
12. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients With Multiple Sclerosis: A Study of Diagnostic Accuracy, Archives of Clinical Neuropsychology (2023)
13. Diet and Disease-Related Outcomes in Multiple Sclerosis: A Systematic Review of Clinical Trials, Current Journal of Neurology (2022)
14. Dietary Fish Intake and the Risk of Multiple Sclerosis: A Systematic Review and Meta-Analysis of Observational Studies, Nutritional Neuroscience (2022)
15. Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? an Mrs Study in Patients With Ms, American Journal of Neuroradiology (2022)
16. Effects of Nonconsecutive Sessions of Transcranial Direct Current Stimulation and Stationary Cycling on Walking Capacity in Individuals With Multiple Sclerosis, International Journal of MS Care (2022)
17. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
18. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
19. Mindfulness-Based Cognitive Therapy Combined With Repetitive Transracial Magnetic Stimulation (Rtms) on Information Processing and Working Memory of Patients With Multiple Sclerosis, Caspian Journal of Internal Medicine (2022)
20. Occupational and Individual Factors Associated With Return to Work in Workers With Multiple Sclerosis; [Multipl Sklerozlu Iscilerde Ise Donus Ile Iliskili Mesleki Ve Bireysel Faktorler], Turk Noroloji Dergisi (2022)
21. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
22. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
23. Research Paper: Covid-19 and Its Outcomes in Multiple Sclerosis Patients, Caspian Journal of Neurological Sciences (2022)
24. The Enigmatic Role of Macrophage Inhibitory Factor (Mif) in the Pathogenesis of Multiple Sclerosis (Ms), Journal of the Neurological Sciences (2022)
25. Developing a Multi-Channel Beamformer by Enhancing Spatially Constrained Ica for Recovery of Correlated Eeg Sources, Journal of Biomedical Physics and Engineering (2021)
26. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
27. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
28. Sars-Cov-2 and Stroke Characteristics: A Report From the Multinational Covid-19 Stroke Study Group, Stroke (2021)
29. Sars-Cov-2 and Stroke Characteristics: A Report From the Multinational Covid-19 Stroke Study Group, Stroke (2021)
30. The Trend of Incidence, Prevalence, and Daly of Multiple Sclerosis in the Middle East and Northern Africa Region Compared to Global, West Europe And, Iran's Corresponding Values During 1990–2017: Retrieved From Global Burden of Diseases Data, Multiple Sclerosis and Related Disorders (2021)
31. Impact of an Existential-Spiritual Intervention Compared With a Cognitive-Behavioral Therapy on Quality of Life and Meaning in Life Among Women With Multiple Sclerosis, Iranian Journal of Psychiatry (2020)
32. Inhibition of Protein Disulfide Isomerase Has Neuroprotective Effects in a Mouse Model of Experimental Autoimmune Encephalomyelitis, International Immunopharmacology (2020)
33. Multiparametric Qmti Assessment and Monitoring of Normal Appearing White Matter and Classified T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis, IRBM (2020)
34. Necrotizing Fungal Osteomyelitis and Fingolimod, 4 Years After Treatment With Fingolimod, Multiple Sclerosis and Related Disorders (2020)
35. Safety and Efficacy of Memantine for Multiple Sclerosis-Related Fatigue: A Pilot Randomized, Double-Blind Placebo-Controlled Trial, Journal of the Neurological Sciences (2020)
36. The Effects and Side Effects of Laquinimod for the Treatment of Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis of Clinical Trials, European Journal of Clinical Pharmacology (2020)
37. A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluating the Trend of Cytokines to Vitamin a Supplementation in Autoimmune Diseases, Clinical Nutrition (2019)
38. Autoimmune Diseases Associated With Neuromyelitis Optica Spectrum Disorders: A Literature Review, Multiple Sclerosis and Related Disorders (2019)
39. C/Ebp Homologous Protein Investigation in the Serum and Cerebro-Spinal Fluid of Relapsing-Remitting Multiple Sclerosis Patients, Journal of Clinical Neuroscience (2019)
40. Calcitriol, But Not Fgf23, Increases in Csf and Serum of Ms Patients, Journal of Neuroimmunology (2019)
41. Computer-Aided Classifying and Characterizing of Methamphetamine Use Disorder Using Resting-State Eeg, Cognitive Neurodynamics (2019)
42. Increased Expression of Endoplasmic Reticulum Stress-Related Caspase-12 and Chop in the Hippocampus of Eae Mice, Brain Research Bulletin (2019)
43. The Effect of Retinyl-Palmitate on the Level of Pro and Anti-Inflammatory Cytokines in Multiple Sclerosis Patients: A Randomized Double Blind Clinical Trial, Clinical Neurology and Neurosurgery (2019)
44. Cerebral Hyperperfusion Syndrome, an Unusual But Disastrous Complication of Carotid Recanalization: A Case Report, Journal of Stroke and Cerebrovascular Diseases (2018)
45. Developing a National Guideline for Diagnosis, Treatment and Follow-Up of Stroke, Journal of Mazandaran University of Medical Sciences (2018)
46. Differential Expression of Klotho in the Brain and Spinal Cord Is Associated With Total Antioxidant Capacity in Mice With Experimental Autoimmune Encephalomyelitis, Journal of Molecular Neuroscience (2018)
47. Minocycline Decreases Cd36 and Increases Cd44 in Lps-Induced Microglia, Journal of Neuroimmunology (2018)
48. Role of Hhv-6 Subtypes in Accelerating Eae Progression, Proceedings of the National Academy of Sciences of the United States of America (2018)
49. Safety and Efficacy of Nanocurcumin As Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial, Neurotherapeutics (2018)
50. The Effect of Minocycline on Indolamine 2, 3 Dioxygenase Expression and the Levels of Kynurenic Acid and Quinolinic Acid in Lps-Activated Primary Rat Microglia, Cytokine (2018)
51. Worldwide Prevalence of Familial Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2018)
52. A Robust Beamforming Approach for Early Detection of Readiness Potential With Application to Brain-Computer Interface Systems, Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society# EMBS (2017)
53. Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab, Annals of Neurology (2017)
54. Soluble Cd40 Ligand Derived From Serum Is Not Correlated With Early Ms, Multiple Sclerosis and Related Disorders (2017)
55. The Human Olfactory System: Cortical Brain Mapping Using Fmri, Iranian Journal of Radiology (2017)
56. 1H-Mrs Metabolite's Ratios Show Temporal Alternation in Temporal Lobe Seizure: Comparison Between Interictal and Postictal Phases, Epilepsy Research (2016)
57. 1H-Mrs Metabolite's Ratios Show Temporal Alternation in Temporal Lobe Seizure: Comparison Between Interictal and Postictal Phases, Epilepsy Research (2016)
58. Effect of Vitamin a Supplementation on Fatigue and Depression in Multiple Sclerosis Patients: A Double-Blind Placebo-Controlled Clinical Trial, Iranian Journal of Allergy# Asthma and Immunology (2016)
59. Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study, Headache (2016)
60. Multiple Sclerosis Influences on the Augmentation of Serum Klotho Concentration, Journal of the Neurological Sciences (2016)
61. Neuromyelitis Optica and Pregnancy, Acta Neurologica Belgica (2016)
62. Retinyl Palmitate Supplementation Modulates T-Bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients, Journal of Molecular Neuroscience (2016)
63. Trends of Quality of Life Changes in Amyotrophic Lateral Sclerosis Patients, Journal of the Neurological Sciences (2016)
64. Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2015)
65. Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2015)
66. Decreased Concentration of Klotho in the Cerebrospinal Fluid of Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Neuroimmunology (2015)
67. Decreased Urinary Level of Melatonin As a Marker of Disease Severity in Patients With Multiple Sclerosis, Iranian Journal of Allergy# Asthma and Immunology (2015)
68. Emerging Tumefactive Ms After Switching Therapy From Interferon-Beta to Fingolimod: A Case Report, Multiple Sclerosis and Related Disorders (2015)
69. Granulocyte Colony-Stimulating Factor for Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study of Iranian Patients, Journal of Clinical Neurology (Korea) (2015)
70. Immunosuppressive Drugs, an Emerging Cause of Posterior Reversible Encephalopathy Syndrome: Case Series, Journal of Stroke and Cerebrovascular Diseases (2015)
71. Impact of Melatonin on Motor, Cognitive and Neuroimaging Indices in Patients With Multiple Sclerosis, Iranian Journal of Allergy# Asthma and Immunology (2015)
72. Impact of Vitamin a Supplementation on Disease Progression in Patients With Multiple Sclerosis, Archives of Iranian Medicine (2015)
73. Neuromyelitis Optica and Nucleotide Variations of Aquaporin-4 Gene, Iranian Journal of Ophthalmology (2015)
74. Quantification of Diagnostic Biomarkers to Detect Multiple Sclerosis Lesions Employing 1H-Mrsi at 3T, Australasian Physical and Engineering Sciences in Medicine (2015)
75. Seroprevalence of Nmo-Igg Antibody in Neuromyelitis Optica (Nmo) and Its Specificity in Differentiating Nmo From Other Demyelinating Diseases With Overlap Symptoms: An Iranian Experience, Iranian Journal of Allergy# Asthma and Immunology (2015)
76. The Effect of Vitamin a Supplementation on Foxp3 and Tgf-Β Gene Expression in Avonex-Treated Multiple Sclerosis Patients, Journal of Molecular Neuroscience (2015)